Abstract
Background
Data regarding long-term outcomes following percutaneous cholecystostomy (PC) are limited, and comparisons to cholecystectomy (CCY) are lacking. We hypothesized that chronic disease burden would predict 1-year mortality following PC, and that outcomes following PC and CCY would be similar when controlling for preprocedural risk factors.
Methods
We performed a 10-year retrospective cohort analysis of patients with acute cholecystitis managed by PC (n = 114) or CCY (n = 234). Treatment response was assessed by systemic inflammatory response syndrome (SIRS) criteria at PC/CCY and 72 h later. Logistic regression identified predictors of 30-day and 1-year mortality following PC. PC and CCY patients were matched by age, Tokyo Guidelines (TG13) cholecystitis severity grade, and VASQIP calculator predicted mortality (n = 42/group).
Results
The presence of SIRS at 72 h following PC was associated with 30-day mortality [OR 8.9 (95% CI 2.6–30)]. SIRS at 72 h was present in and 21.4% of all PC patients, significantly higher than unmatched CCY patients (4.7%, p = 0.048). Independent predictors of 1-year mortality following PC were DNR status [19.7 (2.1–186)], disseminated cancer [7.5 (2.1–26)], and congestive heart failure [3.9 (1.4–11)]. PC patients with none of these risk factors had 17.9% 90-day mortality and no deaths after 90 days; late deaths continued to occur among patients with DNR, CHF, or disseminated cancer. At baseline, PC patients had greater acute and chronic disease burden than CCY patients. After matching, PC and CCY patients had similar age (69 vs. 70 years), TG13 grade (2.4 vs. 2.4), and predicted 30-day mortality (5.5 vs. 6.8%). Matched PC patients had higher 30-day mortality (14.3 vs. 2.4%, p = 0.109) and 180-day mortality (28.6 vs. 7.1%, p = 0.048).
Conclusions
Treatment response to PC predicted 30-day mortality; DNR status, and chronic diseases predicted 1-year mortality. Although the matching procedure did not eliminate selection bias, PC was associated with persistent systemic inflammation and higher long-term mortality than CCY.
Similar content being viewed by others
References
Gurusamy KS, Rossi M, Davidson BR (2013) Percutaneous cholecystostomy for high-risk surgical patients with acute calculous cholecystitis. Cochrane Database Syst Rev 8:CD007088
Winbladh A, Gullstrand P, Svanvik J, Sandstrom P (2009) Systematic review of cholecystostomy as a treatment option in acute cholecystitis. HPB 11:183–193
Duszak R Jr, Behrman SW (2012) National trends in percutaneous cholecystostomy between 1994 and 2009: perspectives from medicare provider claims. J Am Coll Radiol 9:474–479
Patel PP, Daly SC, Velasco JM (2015) Training vs practice: a tale of opposition in acute cholecystitis. World J Hepatol 7:2470–2473
Cull JD, Velasco JM, Czubak A, Rice D, Brown EC (2014) Management of acute cholecystitis: prevalence of percutaneous cholecystostomy and delayed cholecystectomy in the elderly. J Gastrointest Surg 18:328–333
Kamalapurkar D, Pang TC, Siriwardhane M, Hollands M, Johnston E, Pleass H, Richardson A, Lam VW (2015) Index cholecystectomy in grade II and III acute calculous cholecystitis is feasible and safe. ANZ J Surg 85:854–859
Strasberg SM, Pucci MJ, Brunt LM, Deziel DJ (2016) Subtotal cholecystectomy-"fenestrating” vs “reconstituting” subtypes and the prevention of bile duct injury: definition of the optimal procedure in difficult operative conditions. J Am Coll Surg 222:89–96
Davies MG, Hagen PO (1997) Systemic inflammatory response syndrome. Br J Surg 84:920–935
Yokoe M, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Gomi H, Pitt HA, Gouma DJ, Garden OJ, Buchler MW, Kiriyama S, Kimura Y, Tsuyuguchi T, Itoi T, Yoshida M, Miura F, Yamashita Y, Okamoto K, Gabata T, Hata J, Higuchi R, Windsor JA, Bornman PC, Fan ST, Singh H, de Santibanes E, Kusachi S, Murata A, Chen XP, Jagannath P, Lee S, Padbury R, Chen MF, Tokyo Guidelines Revision C (2012) New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci 19:578–585
(2007) Tokyo Guidelines for the management of acute cholangitis and cholecystitis. Proceedings of a consensus meeting, April 2006 Tokyo, Japan. J Hepatobiliary Pancreat Surg 14: 1–121
Mayumi T, Takada T, Kawarada Y, Nimura Y, Yoshida M, Sekimoto M, Miura F, Wada K, Hirota M, Yamashita Y, Nagino M, Tsuyuguchi T, Tanaka A, Gomi H, Pitt HA (2007) Results of the Tokyo Consensus Meeting Tokyo Guidelines. J Hepatobiliary Pancreat Surg 14:114–121
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, STROBE Initiative (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 4:e296
Carter JV, Pan J, Rai SN, Galandiuk S (2016) ROC-ing along: evaluation and interpretation of receiver operating characteristic curves. Surgery 159(6):1638–1645
Lusted LB (1971) Signal detectability and medical decision-making. Science 171:1217–1219
DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845
McCloskey CA, Wilson MA, Hughes SJ, Eid GM (2007) Laparoscopic colorectal surgery is safe in the high-risk patient: a NSQIP risk-adjusted analysis. Surgery 142: 594–597. discussion 597 e591–592
Dwyer JG, Reynoso JF, Seevers GA, Schmid KK, Muralidhar P, Konigsberg B, Lynch TG, Johanning JM (2014) Assessing preoperative frailty utilizing validated geriatric mortality calculators and their association with postoperative hip fracture mortality risk. Geriatr Orthop Surg Rehabil 5:109–115
Johnson MS, Bailey TL, Schmid KK, Lydiatt WM, Johanning JM (2014) A frailty index identifies patients at high risk of mortality after tracheostomy. Otolaryngol Head Neck Surg 150:568–573
Afshar AH, Virk N, Porhomayon J, Pourafkari L, Dosluoglu HH, Nader ND (2015) The validity of the VA surgical risk tool in predicting postoperative mortality among octogenarians. Am J Surg 209:274–279
Akyurek N, Salman B, Yuksel O, Tezcaner T, Irkorucu O, Yucel C, Oktar S, Tatlicioglu E (2005) Management of acute calculous cholecystitis in high-risk patients: percutaneous cholecystotomy followed by early laparoscopic cholecystectomy. Surg Laparosc Endosc Percutan Tech 15:315–320
Hatzidakis AA, Prassopoulos P, Petinarakis I, Sanidas E, Chrysos E, Chalkiadakis G, Tsiftsis D, Gourtsoyiannis NC (2002) Acute cholecystitis in high-risk patients: percutaneous cholecystostomy vs conservative treatment. Eur Radiol 12:1778–1784
Gurusamy K, Samraj K, Gluud C, Wilson E, Davidson BR (2010) Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg 97:141–150
Zafar SN, Obirieze A, Adesibikan B, Cornwell EE, 3rd, Fullum TM, Tran DD (2015) Optimal time for early laparoscopic cholecystectomy for acute cholecystitis. JAMA Surg 150:129–136
Dimou FM, Adhikari D, Mehta HB, Riall TS (2017) Outcomes in older patients with grade III cholecystitis and cholecystostomy tube placement: a propensity score analysis. J Am Coll Surg. doi:10.1016/j.jamcollsurg.2016.12.021
Ambe PC, Kaptanis S, Papadakis M, Weber SA, Zirngibl H (2015) Cholecystectomy vs. percutaneous cholecystostomy for the management of critically ill patients with acute cholecystitis: a protocol for a systematic review. Syst Rev 4:77
Smith T, Li X, Nylander W, Gunnar W (2016) Thirty-day postoperative mortality risk estimates and 1-year survival in veterans health administration surgery patients. JAMA Surg 151(5):417–422. doi:10.1001/jamasurg.2015.4882
McDermott K, Maynard C, Trivedi R, Lowy E, Fihn S (2012) Factors associated with presenting > 12 hours after symptom onset of acute myocardial infarction among Veteran men. BMC Cardiovasc Disord 12:82
Kortram K, van Ramshorst B, Bollen TL, Besselink MG, Gouma DJ, Karsten T, Kruyt PM, Nieuwenhuijzen GA, Kelder JC, Tromp E, Boerma D (2012) Acute cholecystitis in high risk surgical patients: percutaneous cholecystostomy versus laparoscopic cholecystectomy (CHOCOLATE trial): study protocol for a randomized controlled trial. Trials 13:7
Acknowledgements
The authors thank Dr. Loretta Coady-Fariborzian for her assistance in obtaining IRB approval.
Funding
Tyler J. Loftus was supported by post-graduate training grant (Grant No. T32 GM-08721) from the National Institute of General Medical Sciences (NIMGS). Alicia M. Mohr was supported by (Grant No. P50 GM111152–010) and (Grant No. R01 GM105893-01) from the NIGMS.
Author contributions
TJL, EMC, and WJZ contributed to the study design. TJL, EMC, CGD, and ANH contributed to data collection and analysis. AMM, RMT, and CEH contributed to data analysis and critical revisions. GAS and WJZ contributed to the study design, data analysis, and critical revisions.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Tyler J. Loftus, Elisha M. Collins, Camille G. Dessaigne, Amber N. Himmler, Alicia M. Mohr, Ryan M. Thomas, Charles E. Hobson, George A. Sarosi Jr. and William J. Zingarelli have no conflicts of interest to disclose.
Rights and permissions
About this article
Cite this article
Loftus, T.J., Collins, E.M., Dessaigne, C.G. et al. Percutaneous cholecystostomy: prognostic factors and comparison to cholecystectomy. Surg Endosc 31, 4568–4575 (2017). https://doi.org/10.1007/s00464-017-5517-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-017-5517-x